The Discovery and Early Clinical Evaluation of the HCV NS3/4A Protease Inhibitor Asunaprevir (BMS-650032)
- Authors
- A Ali
- A Ammazzalorso
- A Chatterjee
- A Geddawy
- AJ Muir
- AM Ahmed
- AS Lok
- AS Lok
- AS Perelson
- AU Neumann
- B Imperiali
- B Shu
- BC Doak
- BC Doak
- BL Venables
- C Pasquinelli
- C Reviriego
- C Sarrazin
- C Steinkühler
- CA Lipinski
- CA Lipinski
- CN Hayes
- D Ge
- DA Steinhauer
- DI Soumana
- E Palumbo
- E Shudo
- EG Hilgenfeldt
- EJ Gane
- F McPhee
- F McPhee
- F McPhee
- F Poordad
- G Campagnola
- G Li
- GM Keating
- H Gunaydin
- H Kumada
- H Kumada
- H Sezaki
- H Suzuki
- H Toyoda
- H Zhao
- I Esposito
- I Gentile
- J Gong
- J Li
- J Toyota
- JD Graci
- JD Zeuli
- JH Kao
- JN Barr
- K Chayama
- K Chayama
- KW Mosure
- L Rong
- L Rong
- M Belema
- M Belema
- M Gao
- M Llinàs-Brunet
- M Rossi Sebastiano
- MS Sulkowski
- N Akamatsu
- N Akuta
- NA Meanwell
- NA Meanwell
- NA Meanwell
- NA Meanwell
- O Falade-Nwulia
- O Langendorff
- P Heidler
- P Ingallinella
- PM Scola
- PM Scola
- R Sanjuán
- RG Gentles
- RM Poole
- RM Ribeiro
- RT Chung
- S Jenkins
- S Susser
- S Venkataraman
- SF Elena
- SS Yang
- T Asselah
- T Eley
- T Eley
- T Eley
- T Eley
- T Hassanein
- T Kanda
- U Spengler
- V Suppiah
- X Zhang
- Y Suzuki
- Y Tanaka
- Publication date
- Publisher
- 'Springer Science and Business Media LLC'
- Doi
Abstract
Abstract is not available.Similar works
Available Versions
Last time updated on 10/08/2021